ContractCollaboration and License Option Agreement • September 8th, 2020
Contract Type FiledSeptember 8th, 2020Exelixis and NBE-Therapeutics Enter Into Exclusive Collaboration and License Option Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer